-4.55% for Tilray stock as disappointing earnings hit sentiment

Traders Union
All News
Financial News
Tilray slides 4.55% today to $5.25

Highlights

Tilray reported a quarterly loss of $0.24 per share with revenue of $206.73 million, missing market expectations and reinforcing operational challenges.
The acquisition of Lyphe Group expands Tilray’s medical cannabis presence in the UK, potentially supporting long-term patient access and digital health integration.
TLRY trades well below major moving averages with weak trend momentum, and the technical outlook favors further downside within a $5.15–$5.45 consolidation range.

Quarterly loss and UK expansion as sentiment remains negative

Tilray reported a quarterly loss of $0.24 per share on April 1, with revenue of $206.73 million, falling short of market expectations and confirming ongoing weakness in core operations. The company also finalized its acquisition of the Lyphe Group, expanding its medical cannabis presence in the UK and enhancing patient access and digital healthcare services, which may benefit long-term growth. These developments have been accompanied by persistent selling in the stock.

Bearish momentum as negative oscillators meet weak trend

The SMA-20 is positioned at $6.24, with the SMA-50 at $6.54 and the SMA-200 at $9.71, all well above the current price. The Ichimoku Kijun level stands at $7.31 and acts as the nearest resistance. Oscillator signals are negative: MACD points to a bearish direction, and the ADX on the daily timeframe is low at 11.79, indicating a weak trend. Both RSI (36.07) and Stoch RSI (13.74) are deep in oversold territory, with CCI at -88.52, while the BBP reading of -0.28 highlights ongoing seller dominance. The Awesome Oscillator is negative, further supporting the downward momentum.

Sideways or lower price likely as bullish signals stay absent

Over the next five trading days, the typical volatility band is expected to range from $5.15 to $5.45. With recent oversold readings and a lack of bullish signals, the baseline scenario calls for sideways movement or further downside within this zone. A sustained move above $5.45 would open the way to $7.31 as resistance, though such a rebound currently appears unlikely. Any breakdown below $5.15 would expose Tilray to fresh lows amid limited technical support.

Anton Kharitonov, analyst at Traders Union, sees persistent technical weakness and cautious sentiment in Tilray following the disappointing earnings and ongoing pressure on price. The recent UK expansion may help the long-term story, but fundamentals remain soft and momentum signals are definitively negative. He warns that volatility is likely to remain elevated, with little indication of an imminent recovery. "As long as Tilray trades under $5.45, I see no technical case for a bullish reversal and remain defensive on the stock."

Earlier, analysts noted that Tilray was experiencing persistent bearish momentum despite strategic attempts to expand its beverage and UK operations. The latest quarterly loss and continued technical weakness reinforce the prevailing downside risk, making any sustained move above $5.45 a critical signal for trend reversal in the near term.

Source of Data: TLRY Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.